Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 5, 2007

Health Discovery Files Patent for Prostate Cancer Biomarker Discovery

  • Health Discovery (HDC) filed a patent for U.S. and foreign protection for a newly discovered prostate cancer biomarker expression signature. "This new and exciting biomarker discovery could play a significant role in a more accurate diagnosis of prostate cancer as well as could provide important information for the development of new drug targets for the successful treatment of prostate cancer," comments Herbert A. Fritsche, Ph.D., professor of laboratory medicine at the University of Texas M.D. Anderson Cancer Center and chairman of HDC's science team.

    "As medicine becomes increasingly personalized, discoveries of this nature could facilitate the development of new diagnostic tests and innovative treatments for prostate cancer," adds Dr. Fritsche.

    According to a recent paper published in the Journal of Urology by Tom Stamey, M.D., at Stanford University Medical Center and a member of HDC’s science team, the era of prostate specific antigen (PSA) is over because of its low accuracy rate in identifying clinically significant prostate cancer. Dr. Stamey believes that a more accurate test is needed to effectively detect this type of cancer.

    "I firmly believe that this new prostate cancer biomarker discovery provides a significant opportunity towards providing a more accurate diagnosis of prostate cancer and important new information for identifying new therapeutic targets in treating this potentially devastating type of cancer," states Stephen D. Barnhill, M.D., chairman & CEO.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »